144 related articles for article (PubMed ID: 35302756)
1. Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells.
Lu D; Foley CA; Birla SV; Hepperla AJ; Simon JM; James LI; Hathaway NA
ACS Synth Biol; 2022 Apr; 11(4):1397-1407. PubMed ID: 35302756
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery.
Chiarella AM; Butler KV; Gryder BE; Lu D; Wang TA; Yu X; Pomella S; Khan J; Jin J; Hathaway NA
Nat Biotechnol; 2020 Jan; 38(1):50-55. PubMed ID: 31712774
[TBL] [Abstract][Full Text] [Related]
3. Targeted Gene Repression Using Novel Bifunctional Molecules to Harness Endogenous Histone Deacetylation Activity.
Butler KV; Chiarella AM; Jin J; Hathaway NA
ACS Synth Biol; 2018 Jan; 7(1):38-45. PubMed ID: 29073761
[TBL] [Abstract][Full Text] [Related]
4. Efficient and Orthogonal Transcription Regulation by Chemically Inducible Artificial Transcription Factors.
Nomura W; Matsumoto D; Sugii T; Kobayakawa T; Tamamura H
Biochemistry; 2018 Nov; 57(45):6452-6459. PubMed ID: 30366497
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
6. A review on CRISPR/Cas-based epigenetic regulation in plants.
Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 in epigenetics studies of health and disease.
Sar P; Dalai S
Prog Mol Biol Transl Sci; 2021; 181():309-343. PubMed ID: 34127198
[TBL] [Abstract][Full Text] [Related]
8. Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation.
Mahas A; Neal Stewart C; Mahfouz MM
Biotechnol Adv; 2018; 36(1):295-310. PubMed ID: 29197619
[TBL] [Abstract][Full Text] [Related]
9. DNA Methylation Editing by CRISPR-guided Excision of 5-Methylcytosine.
Devesa-Guerra I; Morales-Ruiz T; Pérez-Roldán J; Parrilla-Doblas JT; Dorado-León M; García-Ortiz MV; Ariza RR; Roldán-Arjona T
J Mol Biol; 2020 Mar; 432(7):2204-2216. PubMed ID: 32087201
[TBL] [Abstract][Full Text] [Related]
10. Strong gene activation in plants with genome-wide specificity using a new orthogonal CRISPR/Cas9-based programmable transcriptional activator.
Selma S; Bernabé-Orts JM; Vazquez-Vilar M; Diego-Martin B; Ajenjo M; Garcia-Carpintero V; Granell A; Orzaez D
Plant Biotechnol J; 2019 Sep; 17(9):1703-1705. PubMed ID: 31034138
[No Abstract] [Full Text] [Related]
11. Beyond Native Cas9: Manipulating Genomic Information and Function.
Mitsunobu H; Teramoto J; Nishida K; Kondo A
Trends Biotechnol; 2017 Oct; 35(10):983-996. PubMed ID: 28739220
[TBL] [Abstract][Full Text] [Related]
12. Proximal binding of dCas9 at a DNA double strand break stimulates homology-directed repair as a local inhibitor of classical non-homologous end joining.
Feng YL; Liu SC; Chen RD; Sun XN; Xiao JJ; Xiang JF; Xie AY
Nucleic Acids Res; 2023 Apr; 51(6):2740-2758. PubMed ID: 36864759
[TBL] [Abstract][Full Text] [Related]
13. Increasing Genome Editing Efficiency of Cas9 Nucleases by the Simultaneous Use of Transcriptional Activators and Histone Acetyltransferase Activator.
Liu J; Li B; Yang L; Ren N; Xu M; Huang Q
CRISPR J; 2022 Dec; 5(6):854-867. PubMed ID: 36374245
[TBL] [Abstract][Full Text] [Related]
14. Concatenated Coiled-Coil Tag for Highly Efficient, Small Molecule-Inducible Upregulation of Endogenous Mammalian Genes.
Lebar T; Jerala R
Methods Mol Biol; 2023; 2577():197-209. PubMed ID: 36173575
[TBL] [Abstract][Full Text] [Related]
15. Perturbation of Gene Regulation by Genome Editing.
Yeo NC; Church GM
Methods Mol Biol; 2023; 2594():59-68. PubMed ID: 36264488
[TBL] [Abstract][Full Text] [Related]
16. Inducible CRISPR-dCas9 Transcriptional Systems for Sensing and Genome Regulation.
Wu H; Wang F; Jiang JH
Chembiochem; 2021 Jun; 22(11):1894-1900. PubMed ID: 33433941
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas mediated epigenome editing for cancer therapy.
Ansari I; Chaturvedi A; Chitkara D; Singh S
Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
[TBL] [Abstract][Full Text] [Related]
18. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
Prykhozhij SV; Caceres L; Berman JN
Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy.
Maroufi F; Maali A; Abdollahpour-Alitappeh M; Ahmadi MH; Azad M
Epigenomics; 2020 Oct; 12(20):1845-1859. PubMed ID: 33185489
[TBL] [Abstract][Full Text] [Related]
20. Editing of DNA Methylation Patterns Using CRISPR-Based Tools.
Smith J; Banerjee R; Weeks RJ; Chatterjee A
Methods Mol Biol; 2022; 2458():63-74. PubMed ID: 35103962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
